HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Buys $11,109.33 in Stock

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) major shareholder Of America Corp /De/ Bank acquired 477 shares of the stock in a transaction dated Friday, January 13th. The shares were bought at an average price of $23.29 per share, for a total transaction of $11,109.33. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.

HCA Healthcare Trading Up 0.1 %

HCA stock traded up $0.31 during trading on Tuesday, reaching $345.86. The company had a trading volume of 1,226,315 shares, compared to its average volume of 1,348,308. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The business has a 50 day moving average of $325.79 and a 200 day moving average of $340.25. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market cap of $85.15 billion, a P/E ratio of 15.74, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the business earned $5.90 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

Remove Ads

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a $0.72 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's payout ratio is currently 13.11%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Congress Wealth Management LLC DE boosted its stake in HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after purchasing an additional 34 shares in the last quarter. Evergreen Private Wealth LLC lifted its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after buying an additional 35 shares in the last quarter. Mediolanum International Funds Ltd raised its holdings in HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after acquiring an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. boosted its stake in HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after purchasing an additional 40 shares during the last quarter. Finally, Whittier Trust Co. lifted its holdings in shares of HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after purchasing an additional 41 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on HCA shares. Cantor Fitzgerald reiterated an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Morgan Stanley lowered their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Barclays decreased their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. Finally, Bank of America reduced their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.